New vitamin B12 formula tested for better absorption in seniors

NCT ID NCT07665671

Recruiting now Knowledge-focused Sponsor: RDC Clinical Pty Ltd Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 23, 2026 · Updated 5 times

Summary

This Phase IV trial will compare how well a new vitamin B12 supplement (Ampli-B) is absorbed versus standard vitamin B12 in 12 healthy adults aged 50 and older. Each person will take a single dose of both supplements in random order, with a 10-day break in between. The study measures how quickly and how much B12 gets into the blood, aiming to see if the new formulation works better.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Vitamin B12 (as Ampli-B with permeability enhancer and standard cobalamin)
What this could lead to: If successful, this could show that a specially formulated vitamin B12 supplement is absorbed faster or better than standard B12, potentially improving supplementation options.
What could go wrong: This is a very small, early-stage trial in only 12 healthy volunteers, so results may not apply to people with B12 deficiency or other health conditions. The study is not yet recruiting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY VOLUNTEERS

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

RDC Clinical
RECRUITING

Brisbane, Queensland, Australia

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.